Seikagaku Corporation (TYO:4548)
Japan flag Japan · Delayed Price · Currency is JPY
617.00
-4.00 (-0.64%)
Jun 20, 2025, 3:30 PM JST

Seikagaku Company Description

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.

It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, VISCO-3, JOYCLU Gel-One, Hylink, and SUPARTZ FX; ophthalmic surgical aids under the OPEGAN and SHELLGAN brands; surgical aids for endoscopic mucosal resection under the brand name of MucoUp; and HERNICORE for the treatment of lumbar disc herniation.

The company also offers bulk products comprising sodium hyaluronate and sodium chondroitin sulfate for use in pharmaceuticals and cosmetics.

In addition, it develops endotoxin-detecting reagents for use in quality control of injectable pharmaceuticals and medical devices manufacturing processes and water quality control of dialysate under the brands, such as Pyrochrome, ENDOSPECY, TOXICOLOR, etc. Additionally, its products under development include SI-6603 for lumbar disc herniation; SI-614, a modified hyaluronate for dry eyes; SI-613 for knee osteoarthritis; SI-722 to treat interstitial cystitis and bladder pain syndrome; SI-613-ETP to treat enthesopathy; and SI-449, a cross-linked chondroitin sulfate adhesion barrier.

The company was formerly known as K.K. Seikagaku Kenkyusho and changed its name to Seikagaku Corporation in 1962.

Seikagaku Corporation was founded in 1947 and is headquartered in Tokyo, Japan.

Seikagaku Corporation
Country Japan
Founded 1947
Industry Medical Devices
Sector Healthcare
Employees 1,075
CEO Kenji Mizutani

Contact Details

Address:
Marunouchi Center Building
Tokyo, 100-0005
Japan
Phone 81 3 5220 8950
Website seikagaku.co.jp

Stock Details

Ticker Symbol 4548
Exchange Tokyo Stock Exchange
Stock Type Common Stock
Fiscal Year April - March
Reporting Currency JPY
ISIN Number JP3414000004
SIC Code 2834

Key Executives

Name Position
Kenji Mizutani Chief Executive Officer
Kazushi Takeda Chief Financial Officer